Loading stock data...

Biogen Pharmachem Industries L

BSE: BIOGEN

BSE
0.73 -0.01 (-1.35%)

Prev Close

0.74

Open Price

0.73

Volume

853,302

Today Low / High

0.72 / 0.74

52 WK Low / High

0.71 / 1.22

Range

1 - 1

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 0.73, reflecting a change of -0.01 (-1.35135%). The expected target range on the BSE is 1 - 1. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

12 Dec 0.73 0.00%
11 Dec 0.73 1.37%
10 Dec 0.71 1.41%
09 Dec 0.72 -1.39%
08 Dec 0.74 -2.70%
05 Dec 0.75 -2.67%
04 Dec 0.75 -1.33%
03 Dec 0.75 0.00%
02 Dec 0.76 -2.63%
01 Dec 0.76 0.00%
28 Nov 0.78 -2.56%
27 Nov 0.76 2.63%
26 Nov 0.76 1.32%
25 Nov 0.78 -2.56%
24 Nov 0.77 -1.30%
21 Nov 0.79 -3.80%
19 Nov 0.79 -2.53%
18 Nov 0.79 0.00%
17 Nov 0.80 -1.25%
14 Nov 0.81 -2.47%

Biogen Pharmachem Industries L Graph

Biogen Pharmachem Industries L Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Biogen Pharmachem Industries L T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 0.73, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 0.73 0.74 0.66 - 0.81
0.74 0.60 - 0.89
0.75 0.53 - 0.98
Bearish Scenario 0.73 0.72 0.65 - 0.79
0.72 0.57 - 0.86
0.71 0.50 - 0.92

Overview of Biogen Pharmachem Industries L

ISIN

INE703D01023

Industry

Investment - Banking & Investment Services

Vol.Avg

793,597

Market Cap

658,900,190

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

0.90

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for BIOGEN

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 -0.36 Cr 0.18 Cr -0.54 Cr 1.5091 0.00 Cr 0.03 Cr -0.29 Cr -0.29 Cr 0.00 -0.29 Cr 0.8192
2024-03-31 1.61 Cr 0.10 Cr 1.51 Cr 0.9408 0.00 Cr 0.01 Cr 1.16 Cr 1.93 Cr 0.03 1.93 Cr 1.2020
2023-03-31 0.91 Cr 0.20 Cr 0.47 Cr 0.5133 0.00 Cr 0.00 Cr 0.46 Cr 0.46 Cr 0.01 0.46 Cr 0.4990
2022-03-31 2.16 Cr 2.08 Cr 0.08 Cr 0.0390 0.00 Cr 0.01 Cr -0.01 Cr -0.01 Cr 0.00 -0.01 Cr -0.0040
2021-03-31 0.01 Cr 1.49 Cr -1.48 Cr -102.2899 0.00 Cr 0.00 Cr -1.60 Cr -1.60 Cr -0.02 -1.60 Cr -110.8017

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.05 Cr 92.02 Cr 0.09 Cr 91.9277 Cr 0.00 Cr -0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0900 Cr
2024-03-31 0.02 Cr 56.82 Cr 0.30 Cr 56.5204 Cr 0.00 Cr -0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.30 Cr 5.43 Cr 0.3019 Cr
2023-03-31 0.13 Cr 54.83 Cr 0.24 Cr 54.5897 Cr 0.00 Cr -0.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.24 Cr 8.85 Cr 0.2381 Cr
2022-03-31 0.08 Cr 54.95 Cr 0.82 Cr 54.1342 Cr 0.00 Cr -0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.82 Cr 6.95 Cr 0.8154 Cr
2021-03-31 0.01 Cr 54.25 Cr 0.11 Cr 54.1428 Cr 0.06 Cr 0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.11 Cr 0.00 Cr 0.1082 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -1.0910 Cr -32.6096 Cr 35.7000 Cr -1.0820 Cr 1.9993 Cr 2.0163 Cr 0.0000 Cr -0.2927 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 1.9446 Cr -2.0563 Cr 0.0000 Cr 1.9446 Cr -0.1118 Cr 0.0169 Cr 0.0000 Cr 1.9307 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 1.7045 Cr -1.6589 Cr 0.0000 Cr 1.7044 Cr 0.0456 Cr 0.1287 Cr 0.0000 Cr 0.4555 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 1.3983 Cr -1.3226 Cr 0.0000 Cr 1.3983 Cr 0.0757 Cr 0.0832 Cr 0.0000 Cr -0.0086 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 3.9499 Cr -3.6400 Cr -0.3059 Cr 3.9499 Cr 0.0041 Cr 0.0074 Cr 0.0000 Cr -1.6032 Cr -0.3059 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 -0.10 Cr 0.34 Cr -0.44 Cr 4.1973 -0.49 Cr -0.49 Cr -0.01 -0.49 Cr 4.6854
2025-06-30 1.54 Cr 0.06 Cr -0.06 Cr -0.0410 1.34 Cr 1.34 Cr 0.01 1.34 Cr 0.8717
2025-03-31 1.35 Cr 0.09 Cr -0.09 Cr -0.0690 -0.53 Cr 1.18 Cr 0.02 1.18 Cr 0.8710
2024-12-31 0.23 Cr 0.05 Cr -0.05 Cr -0.2219 -0.54 Cr -0.31 Cr 0.00 -0.31 Cr -1.3836
2024-09-30 -0.65 Cr 0.01 Cr -0.01 Cr 0.0158 -0.35 Cr -1.00 Cr -0.02 -1.00 Cr 1.5331

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.05 Cr 1.96 Cr 2.02 Cr 0.07 Cr 0.00 Cr 2.66 Cr 0.00 Cr 92.02 Cr 0.09 Cr
2024-09-30 0.06 Cr 0.27 Cr 0.32 Cr 0.08 Cr 0.00 Cr 1.90 Cr 0.00 Cr 55.46 Cr 0.09 Cr
2024-03-31 0.02 Cr 0.00 Cr 0.02 Cr 0.05 Cr 0.00 Cr 0.09 Cr 0.00 Cr 56.82 Cr 0.30 Cr
2023-09-30 0.02 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.41 Cr 0.00 Cr 61.52 Cr 5.80 Cr
2023-03-31 0.13 Cr 0.00 Cr 0.13 Cr 45.85 Cr 0.00 Cr 45.97 Cr 0.00 Cr 54.83 Cr 0.24 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 0.06 Cr 0.06 Cr 0.00 Cr 0.00 Cr 0.04 Cr 0.06 Cr 0.02 Cr 0.00 Cr 0.06 Cr
2023-09-30 0.72 Cr 0.72 Cr 0.00 Cr 0.00 Cr 0.72 Cr 0.02 Cr -0.70 Cr 0.00 Cr 0.72 Cr
2023-06-30 0.41 Cr 0.41 Cr 0.00 Cr 0.00 Cr 0.28 Cr 0.41 Cr 0.13 Cr 0.00 Cr 0.41 Cr
2023-03-31 -0.20 Cr -0.20 Cr 0.00 Cr 0.00 Cr -0.20 Cr 0.13 Cr 0.33 Cr 0.00 Cr -0.20 Cr
2022-12-31 0.30 Cr 0.30 Cr 0.00 Cr 0.00 Cr 0.28 Cr 0.30 Cr 0.02 Cr 0.00 Cr 0.30 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Investment - Banking & Investment Services

No stocks found in this industry.

Key Executives

Chief Financial Officer & Whole Time Director
Mr. Kelash Bunkar

Gender: male

Year Born: 1996

Company Secretary
Ms. Khushboo Khandelwal

Gender: female

Year Born:

FAQs about Biogen Pharmachem Industries L

Who is the CEO of the company?

The CEO is Kelash Bunkar.

What is the current market price of the stock?

The current price is ₹0.73.

What is the 52-week price range?

The range is ₹0.71-1.22.

What is the market capitalization of the company?

The market capitalization is ₹65.89 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 38.39.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Biogen Pharmachem Industries L (ISIN: INE703D01023) is a leading Investment - Banking & Investment Services in India. With a market capitalization of ₹65.89 crores and an average daily volume of 793,597 shares, it operates in the Investment - Banking & Investment Services. The company last declared a dividend of ₹0.